Medicine Information


Marketing Authorisation - Medicinal Products


Marketing Authorisation: Medicinal Products The case of R (on the application of Merck Sharp and Dohme Ltd) v Licensing Authority [2005], concerned the application for marketing authorisation for a generic product which was based on Product C (see below).

The claimant had marketing authorisations for three medicinal products used in the treatment of osteoporosis and three generic companies sought marketing authorisation for Product C.

Product A - was authorised by the European Community in 1993;

Product B - was authorised in 2000

Product C - was a generic product based on Product B (a copy of Product B).

When a company applies for marketing authorisation for a product, it is a requirement under the European Parliament and Council Directive (EC) 2001/83 (the "Directive"), to supply a full set of data in order to show the safety and efficacy of the product.

There are instances under the Directive when an applicant can simply rely on data submitted in respect of a previously authorised product. For instance, the applicant could refer to data already submitted in respect of a product with marketing authorisation, where the applicant is seeking authorisation for a product 'essentially similar' to a product holding a marketing authorisation for ten years (as per the United Kingdom and pursuant to art 10(i)(a)(iii) of the Directive).

In seeking marketing authorisation for Product C, the generic companies relied on data submitted in relation to Product A and Product B. However, although Product A and Product B contained the same active ingredient, they were not 'essentially similar' within the meaning of the Directive. This meant that they differed in respect of their posology (the schedule of dosage). The defendant accepted that the generic companies did not have to provide any further data but the claimant argued that such an approach was unlawful and in breach of the Directive. The claimant made a reference to the European Court of Justice ("Court of Justice").

The claimant contended that the issue was as yet unresolved by the rules laid down in previous decisions of the ECJ. In particular, it was argued, that there had been no cases where a difference in posology had been the subject of a decision.

The application was dismissed. The ECJ held that:

The principles laid down by the ECJ in earlier decisions were clearly applicable in this case and there was no uncertainty;

Although it was true that a change in posology had not previously been the subject of a decision, it was for the ECJ to interpret the EC Treaty and the relevant principles by which it was to be interpreted, and for the domestic court to apply those principles to the particular case. No new principles arose in the instant case.

If you require further information contact us.

Email: enquiries@rtcoopers.com

RT COOPERS, 2005. This Briefing Note does not provide a comprehensive or complete statement of the law relating to the issues discussed nor does it constitute legal advice. It is intended only to highlight general issues. Specialist legal advice should always be sought in relation to particular circumstances.

Rosanna Cooper is a partner in RT Coopers Solicitors a full service law firm in London. The firm specialises in patents, trade marks, copyright, designs, technology transfer, biotechnology and pharmaceutical law. The firm has a flexible approach to fees and provides the highest quality legal advice.

Contact us at enquiries@rtcoopers.com. visit our website at http://www.rtcoopers.com


MORE RESOURCES:
This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news


Wall Street Journal

It's Early Days for the Use of AI in Medicine
Wall Street Journal
We disagree with your suggestion in “IBM Has a Watson Dilemma” (Exchange, Aug. 11) that IBM has not made enough progress on bringing the benefits of artificial intelligence to health care. It is true that IBM has placed a big bet on health care. We ...

and more »


Flexible drug delivery microdevice to advance precision medicine
Science Daily
Theragnosis, an emerging medical technology, is gaining attention as key factor to advance precision medicine for its featuring simultaneous diagnosis and therapeutics. Theragnosis devices including smart contact lenses and microneedle patches ...

and more »


Phys.Org

Unpublished Egyptian texts reveal new insights into ancient medicine
Phys.Org
The University of Copenhagen in Denmark is home to a unique collection of Ancient Egyptian papyrus manuscripts.

and more »


MLive.com

Michigan Medicine No. 5 in nation in US News hospital rankings
MLive.com
ANN ARBOR, MI - Michigan Medicine continues to earn a reputation as one of the nation's finest health systems, according to the annual U.S. News & World Report rankings released Tuesday, Aug. 14. Michigan Medicine, which includes all of the hospitals ...
Michigan Medicine hospitals ranked No. 5 in the nation by US News & World ReportUniversity of Michigan Health System News (press release)
Michigan Medicine ranks as No. 5 hospital in the nationWXYZ
Northwestern Medicine Central DuPage Hospital ranked among 'Best Hospitals' by US News & World ReportChicago Daily Herald
PhillyVoice.com -Facebook -US News Health - US News & World Report -U.S. News & World Report
all 149 news articles »


12 things transforming the world of medicine and how to adapt
Healio
Deas gave 12 areas of medicine that will have an impact on today's physicians: 1. Artificial intelligence. “Artificial intelligence is real,” Deas said. “It's going to be a significant supplement to what we do because our electronic medical records ...



The Conversation US

The promise of personalized medicine is not for everyone
The Conversation US
Could your medical treatment one day be tailored to your DNA? That's the promise of “personalized medicine,” an individualized approach that has caught the imagination of doctors and researchers over the past few years. This concept is based on the ...

and more »


The Guardian

Think sexism in medicine is unique to Japan? Think again | Van ...
The Guardian
I'd love to insist sexism is localised to Tokyo medical school. But women are devalued in medicine across the west.

and more »


Precision Medicine and Sharing Medical Data in Real Time: Opportunities and Barriers
AJMC.com Managed Markets Network
Sharing massive amounts of medical data is critical to precision medicine. The California Department of Public Health recently started to partner with certain hospitals in the state to better understand cancer trends by collecting and securely sending ...



Fears Grow For Detained Chinese Activist 'Cut Off From Supply of Medicine'
Radio Free Asia
"He had had surgery ... but this illness requires him to take medicine every day," Zhuang said. "The doctor gave him a prescription for traditional Chinese herbal medicine, but his family have been worried because he has been cut off from his supply of ...



Inter Press Service

Let Food Be Thy Medicine
Inter Press Service
Adelheid Onyango is Adviser for Nutrition at the World Health Organization's Regional Office for Africa and Bibi Giyose is Senior Nutrition and Food Systems officer, and Special Advisor to the CEO of the New Partnership for Africa's Development (NEPAD).


Google News

home | site map
© 2007